Respiratory Syncytial Virus (RSV) Infection

DBCOND0079390InfectionsRespiratory Tract Diseases

Respiratory Syncytial Virus (RSV) Infection is the indication for 1 drug in DrugBank. It is covered by 5 curated, structured indications.

Also known as
Respiratory Syncytial Virus Infections · Respiratory Syncytial Virus Infection · RSV Infection · Infections, Respiratory Syncytial Virus · Respiratory Syncytial Virus (RSV) Infections
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0027589SNOMED CT186750007MedDRA10039247UMLSC0035235

What you can answer from here — as of September 30, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
238Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Respiratory Syncytial Virus (RSV) Infection share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In